BioCentury
ARTICLE | Clinical News

Isavuconazole: Phase III amended

July 22, 2013 7:00 AM UTC

Basilea said the time point to assess the primary endpoint of overall response was amended in the double-blind, international Phase III ACTIVE trial of IV and oral isavuconazole to the end of IV treat...